| Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, ... Nature communications 7 (1), 12150, 2016 | 2446 | 2016 |
| Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival S Walter, T Weinschenk, A Stenzl, R Zdrojowy, A Pluzanska, C Szczylik, ... Nature medicine 18 (8), 1254-1261, 2012 | 1597 | 2012 |
| Tumor-induced tolerance and immune suppression depend on the C/EBPβ transcription factor I Marigo, E Bosio, S Solito, C Mesa, A Fernandez, L Dolcetti, S Ugel, ... Immunity 32 (6), 790-802, 2010 | 958 | 2010 |
| Myeloid-derived suppressor cell heterogeneity and subset definition E Peranzoni, S Zilio, I Marigo, L Dolcetti, P Zanovello, S Mandruzzato, ... Current opinion in immunology 22 (2), 238-244, 2010 | 806 | 2010 |
| Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages S Ugel, F De Sanctis, S Mandruzzato, V Bronte The Journal of clinical investigation 125 (9), 3365-3376, 2015 | 546 | 2015 |
| Myeloid‐derived suppressor cell heterogeneity in human cancers S Solito, I Marigo, L Pinton, V Damuzzo, S Mandruzzato, V Bronte Annals of the New York Academy of Sciences 1319 (1), 47-65, 2014 | 436 | 2014 |
| A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma S Mandruzzato, F Brasseur, G Andry, T Boon, P Bruggen The Journal of experimental medicine 186 (5), 785-793, 1997 | 424 | 1997 |
| IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients S Mandruzzato, S Solito, E Falisi, S Francescato, V Chiarion-Sileni, ... The Journal of immunology 182 (10), 6562-6568, 2009 | 401 | 2009 |
| A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells S Solito, E Falisi, CM Diaz-Montero, A Doni, L Pinton, A Rosato, ... Blood, The Journal of the American Society of Hematology 118 (8), 2254-2265, 2011 | 381 | 2011 |
| Myeloid-derived suppressor cells in cancer patients: a clinical perspective AJ Montero, CM Diaz-Montero, CE Kyriakopoulos, V Bronte, ... Journal of immunotherapy 35 (2), 107-115, 2012 | 258 | 2012 |
| Part I: Vaccines for solid tumours S Mocellin, S Mandruzzato, V Bronte, M Lise, D Nitti The Lancet Oncology 5 (11), 681-689, 2004 | 252 | 2004 |
| Immune tolerance to tumor antigens occurs in a specialized environment of the spleen S Ugel, E Peranzoni, G Desantis, M Chioda, S Walter, T Weinschenk, ... Cell reports 2 (3), 628-639, 2012 | 238 | 2012 |
| Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study S Mandruzzato, S Brandau, CM Britten, V Bronte, V Damuzzo, ... Cancer Immunology, Immunotherapy 65, 161-169, 2016 | 228 | 2016 |
| Complexity and challenges in defining myeloid‐derived suppressor cells V Damuzzo, L Pinton, G Desantis, S Solito, I Marigo, V Bronte, ... Cytometry Part B: Clinical Cytometry 88 (2), 77-91, 2015 | 216 | 2015 |
| Identification of genes selectively regulated by IFNs in endothelial cells S Indraccolo, U Pfeffer, S Minuzzo, G Esposito, V Roni, S Mandruzzato, ... The Journal of Immunology 178 (2), 1122-1135, 2007 | 187 | 2007 |
| Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis S Pizzini, A Bisognin, S Mandruzzato, M Biasiolo, A Facciolli, L Perilli, ... BMC genomics 14, 1-14, 2013 | 180 | 2013 |
| A peptide encoded by the human MAGE3 gene and presented by HLA-1344 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3 J Herman, P van der Bruggen, IF Luescher, S Mandruzzato, P Romero, ... Immunogenetics 43, 377-383, 1996 | 154 | 1996 |
| Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 R Trovato, A Fiore, S Sartori, S Canè, R Giugno, L Cascione, S Paiella, ... Journal for immunotherapy of cancer 7, 1-16, 2019 | 153 | 2019 |
| MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas P Dalerba, E Frascella, B Macino, S Mandruzzato, A Zambon, A Rosolen, ... International journal of cancer 93 (1), 85-90, 2001 | 150 | 2001 |
| Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation R Rotondo, M Bertolotto, G Barisione, S Astigiano, S Mandruzzato, ... Journal of leukocyte biology 89 (5), 721-727, 2011 | 147 | 2011 |
